Twenty-four vs. fourty-eight weeks of re-therapy with interferon alpha 2b and ribavirin in Interferon alpha monotherapy relapsers with chronic hepatitis c. Swiss Med Wkly [Internet]. 2003 Aug. 23 [cited 2025 Nov. 5];133(3334):455-60. Available from: https://smw.ch/index.php/smw/article/view/299